BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30629861)

  • 1. Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects.
    Kong R; Laskin OL; Kaushik D; Jin F; Ma J; McIntosh J; Souza M; Almstead N
    Clin Pharmacol Drug Dev; 2019 Feb; 8(2):172-178. PubMed ID: 30629861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects.
    Li Y; Liu L; Gomez D; Chen J; Tong Z; Palmisano M; Zhou S
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00436. PubMed ID: 30386625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects.
    Shibata M; Hatta T; Saito M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
    Clin Drug Investig; 2020 May; 40(5):469-484. PubMed ID: 32274653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and Disposition of Ataluren after Oral Administration to Mice, Rats, Dogs, and Humans.
    Kong R; Ma J; Hwang S; Goodwin E; Northcutt V; Babiak J; Almstead N; McIntosh J
    Drug Metab Dispos; 2020 Apr; 48(4):317-325. PubMed ID: 31980502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects.
    Trivedi A; Malik FI; Mackowski M; Hutton S; Aoki M; Abbasi S; Dutta S; Lee E
    Eur J Drug Metab Pharmacokinet; 2021 Nov; 46(6):759-770. PubMed ID: 34415561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects.
    Willen D; Uhl W; Wolna P; Papasouliotis O; Yalkinoglu Ö
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):27-40. PubMed ID: 31529406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study.
    Shimada S; Vaidya S; Khindri S; Tashiro N; Cheng Y; Hara H; Majumdar T; Woessner R; Furihata K; Kobayashi K
    Int J Clin Pharmacol Ther; 2015 May; 53(5):398-407. PubMed ID: 25740265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of repaglinide in healthy caucasian and Japanese subjects.
    Thomsen MS; Chassard D; Evène E; Nielsen KK; Jørgensen M
    J Clin Pharmacol; 2003 Jan; 43(1):23-8. PubMed ID: 12520624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
    Vutikullird AB; Gillespie M; Song S; Steinfeld J
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.
    Cawello W; Kim SR; Braun M; Elshoff JP; Ikeda J; Funaki T
    Clin Drug Investig; 2014 Feb; 34(2):95-105. PubMed ID: 24178238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects.
    Ermer J; Martin P; Corcoran M; Matsuo Y
    Neuropsychopharmacol Rep; 2020 Mar; 40(1):16-29. PubMed ID: 31765110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.
    Hall J; Gillen M; Liu S; Miner JN; Valdez S; Shen Z; Lee C
    Drug Des Devel Ther; 2018; 12():1799-1807. PubMed ID: 29950814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.
    Taubel J; Ferber G; Lorch U; Batchvarov V; Savelieva I; Camm AJ
    Br J Clin Pharmacol; 2014 Jan; 77(1):170-9. PubMed ID: 23713767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Safety of Mavatrep (JNJ-39439335), a TRPV1 Antagonist in Healthy Japanese and Caucasian Men: A Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Phase 1 Study.
    Manitpisitkul P; Shalayda K; Russell L; Sanga P; Solanki B; Caruso J; Iwaki Y; Moyer JA
    Clin Pharmacol Drug Dev; 2018 Sep; 7(7):712-726. PubMed ID: 29125703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of inclacumab in healthy Japanese and Caucasian subjects.
    Morrison M; Palermo G; Schmitt C
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1365-74. PubMed ID: 26363899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects.
    Zhao Q; Brett M; Van Osselaer N; Huang F; Raoult A; Van Peer A; Verhaeghe T; Hust R
    J Clin Pharmacol; 2002 Sep; 42(9):1002-10. PubMed ID: 12211216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration.
    Miyachi N; Zagrijtschuk O; Kang L; Yonezu K; Qin A
    Clin Drug Investig; 2021 Apr; 41(4):391-404. PubMed ID: 33725322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P
    Juif PE; Dingemanse J; Winkle P; Ufer M
    Clin Transl Sci; 2021 Jan; 14(1):143-147. PubMed ID: 32860737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable pharmacokinetics and pharmacodynamics of melagatran in Japanese and caucasian volunteers after oral administration of the direct thrombin inhibitor ximelagatran.
    Wernevik LC; Nyström P; Andersson M; Johnsson G; Bylock A; Nakanishi T; Eriksson UG
    Clin Pharmacokinet; 2006; 45(1):85-94. PubMed ID: 16430313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.